NCT03088527 2022-08-18
Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer
Stemline Therapeutics, Inc.
Phase 1 Completed
Clinical Trials
3 trialsNCT03594578 2019-10-01
Prospective Thinking in Hormone-Responsive Breast Cancer
Virginia Polytechnic Institute and State University
Phase NA Completed
NCT02025712 2014-01-01
Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Organisation for Oncology and Translational Research
Phase 2 Unknown